HIV Detection and Delayed Diagnosis: A Time Series Analysis in China

Author:

Chen Junfang,Xu Junfang,Zhou Yuyin,Luo Yan

Abstract

Background: Insufficient HIV detection and late presentation to antiretroviral therapy (ART) pose significant public health challenges. In China, universal access to HIV testing is available now. Under this background, we aim to analyze the trends of HIV detection and the prevalence of delayed HIV diagnosis (DHD) in order to provide evidence for HIV prevention and treatment in China. Methods: Data of HIV tests in Hangzhou city between 2007 and 2018 were collected from the Chinese National HIV/AIDS Comprehensive Response Information Management System (CRIMS). Descriptive statistics were used to describe the characteristics of HIV testing and detection and the prevalence of DHD among newly diagnosed HIV cases. Non-parametric tests were employed to examine the prevalence of DHD among newly diagnosed HIV cases. Moreover, logistic regression models were employed to explore the influencing factors of DHD. Results: Testing rates doubled from 14.1% in 2007–2010 to 28.2% in 2016–2018. The total positive rate of HIV tests was 5.3 per 10,000. Preoperative testing was the predominant pathway for HIV tests, accounting for 41.9%, followed by testing for health screening, maternal examination and other patients, accounting for 18.4%, 13.2% and 11.8%, respectively. Meanwhile, the predominant pathway for HIV case detection was also preoperative testing, accounting for 29.1%, followed by testing for other patients, testing at STD clinics and VCT, with the proportions of 18.8%, 15.8% and 13.6%, respectively. MSM (men who have sex with men) contact was the main transmission route, accounting for 55.3%, followed by heterosexual contact, accounting for 41.6%. Overall, DHD occurred in 29.0% of the newly diagnosed cases, and this rate had not improved over the years. A higher prevalence of DHD was found in those diagnosed through a pre-test for receiving blood/products [OR (95%CI): 5.42(2.95–9.97)], detection of other patients [OR (95%CI): 2.08(1.64–2.63)], preoperative testing [OR (95%CI): 1.83(1.44–2.32)] and spouse or sexual partner testing in positive person [OR (95%CI): 1.93(1.34–2.78)] compared with those diagnosed at a VCT clinic. Heterosexuals [OR (95%CI): 1.20(1.06–1.36)] had a higher risk of DHD than MSM. Diagnosis at a CDC [OR (95%CI): 0.68(0.55–0.83)] and community health centers [OR (95%CI): 0.54(0.39–0.75)] had a lower risk of DHD than in hospitals. Older age, males, being single/divorced or widowed and floating population were also associated with DHD. Conclusions: In China, DHD had not improved in the last 10 years, although HIV testing had been expanded. Therefore, it is important for continued efforts to promote early diagnosis of HIV to prevent transmission, morbidity and early mortality in HIV infection.

Funder

China Medical Board

National Natural Science Foundation of China

Hangzhou Agricultural and Social Development Scientific Research General Project

Zhejiang Medical Health Science and Technology Project

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health

Reference19 articles.

1. Progress Towards the 90-90-90 Targets for Controlling HIV-China, 2018;Zhao;CCDC Wkly.,2019

2. Centers for Disease Control and Prevention (2018, January 09). HIV in the United States: At A Glance. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, Available online: http://www.cdc.gov/hiv/statistics/basics/ataglance.html.

3. (2022, September 20). China CDC. Available online: http://www.chinacdc.cn/jkzt/crb/zl/azb/.

4. Did CDC’s 2006 revised HIV testing recommendations make a difference? Evaluation of HIV testing in the US household population, 2003–2010;Woodring;J. Acquir. Immune Defic. Syndr. (1999),2014

5. Analysis on the diagnosis et al. Analysis on the 5/conidentifed HIV/AIDS cases in China, 2010–2014;Jin;Zhonghua Liu Xing Bing Xue Za Zhi,2016

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3